Scroll
To Top

Archives for: June 17th, 2015

Impact of the Orphan Drug Tax Credit on Treatments for Rare Diseases

Written by Jennifer Huron on June 17, 2015

 

Today, the National Organization for Rare Disorders (NORD), Biotechnology Industry Organization (BIO), and Ernst & Young released “Impact of the Orphan Drug Tax Credit on Treatments for Rare Diseases,” a new white paper examining the role of the Orphan Drug Tax Credit (ODTC) on rare disease drug discovery.   Patients share… Read More